Kevin A. Maupin
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
48
Citations
904
Est. group size
—
Recurring co-author estimate
Active years
17
Publishing since 2010
Kevin A. Maupin studies the biology of bone and cancer using molecular and imaging approaches. Earlier work examined how specific genes and glycan-binding proteins (such as galectin-3) affect bone mass and structure in mice, while more recent projects focus on nuclear-medicine imaging and radioligand therapies for prostate, pancreatic, and other cancers, as well as data-driven analysis of skeletal traits and fracture risk.
Publication activity has been fairly steady at a low-to-moderate level over the past decade, peaking around 2019 and averaging about two papers per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- DXA-Derived Skeletal Phenotypes and Hip Fracture Risk: A Backdoor-Adjusted Causal Analysis
arXiv (Cornell University) · 2026
- DXA-Derived Skeletal Phenotypes and Hip Fracture Risk: A Backdoor-Adjusted Causal Analysis
arXiv (Cornell University) · 2026
- Evaluating the Efficacy and Safety of Pluvicto in Chemotherapy-Ineligible Nonagenarians: A Descriptive Case Series
Cureus · 2025
- Prostate-Specific Membrane Antigen Positron Emission Tomography-Detected Intrahepatic Cholangiocarcinoma in a Patient With Metastatic Castration-Resistant Prostate Cancer: Dual Cancer Management With Pluvicto and Intensity-Modulated Radiation Therapy
Cureus · 2025
- First-in-Human Total-Body PET/CT Imaging Using<sup>89</sup>Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
Journal of Nuclear Medicine · 2024
- Ga-68 PSMA-11 impacting prostate cancer management in a real-world setting: A pilot experience using the total-body PET/CT scanner.
Journal of Clinical Oncology · 2023
- Mutation of the galectin‐3 glycan‐binding domain ( <scp> <i>Lgals3‐</i> R200S </scp> ) enhances cortical bone expansion in male mice and trabecular bone mass in female mice
FEBS Open Bio · 2022
- Augmented alpha-beta PSMA radioligand therapy in metastatic prostate cancer: Analysis of prognostic factors for survival.
Journal of Clinical Oncology · 2022
- Mutation of the Galectin-3 Glycan Binding Domain ( <i>Lgals3</i> -R200S) Enhances Cortical Bone Expansion in Male and Trabecular Bone Mass in Female Mice
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Loss of Lgals3 Protects Against Gonadectomy-Induced Cortical Bone Loss in Mice
Calcified Tissue International · 2019
- Enhanced cortical bone expansion in Lgals3-deficient mice during aging
Bone Research · 2018
- Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover
Bone · 2017
- PMC×4
- Bone×3
- npj Microgravity×2
- Journal of Clinical Oncology×2
- Cureus×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile